Want to see FR:SAVE full AI Analyst Report?

Savencia (SAVE) Price & Analysis

4 Followers

SAVE Stock Chart & Stats

€63.00

€0.40(0.63%)

At close: Jul 27 4:00 PM EDT

€63.00

€0.40(0.63%)

Day’s Range― - ―

52-Week Range€54.20 - €74.40

Previous CloseN/A

Volume722.00

Average Volume (3M)1.10K

Market Cap

€768.04M

Enterprise Value€2.09B

Total Cash (Recent Filing)€726.99M

Total Debt (Recent Filing)€1.70B

Price to Earnings (P/E)9.7

Beta0.30

Next Earnings

Mar 11, 2027

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield2.5%

Share Statistics

EPS (TTM)5.55

Shares Outstanding14,032,930

10 Day Avg. Volume1,204

30 Day Avg. Volume1,104

Financial Highlights & Ratios

PEG Ratio-0.38

Price to Book (P/B)0.52

Price to Sales (P/S)0.13

P/FCF Ratio14.73

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)10.52

Revenue Forecast (FY)€7.77B

Bulls Say, Bears Say

Bulls Say

Manageable LeverageLeverage remains moderate for a packaged-foods company, and equity has stayed relatively stable over time. This provides Savencia with a stronger financial base than a highly indebted peer, preserving capacity to manage obligations and fund operations despite modest returns.

Diversified Sales ChannelsSavencia serves consumers, foodservice operators, professional customers, and industrial clients rather than relying on one route to market. This multi-channel model can broaden demand sources, support recurring volume-based orders, and improve commercial resilience over the coming quarters.

Established Operating ScaleThe company has demonstrated substantial operating scale and a relatively solid gross-margin structure over several years. That foundation indicates established products and distribution capabilities, giving Savencia a platform from which to restore growth and protect profitability.

Bears Say

Recent Revenue ContractionThe reversal from multi-year revenue expansion to a 2.8% decline in 2025 signals weaker recent demand or execution. Sustained top-line contraction would reduce operating leverage, limit reinvestment capacity, and make recovery dependent on renewed volume or pricing progress.

Thin And Declining ProfitabilityA very thin net margin leaves limited protection against cost pressure, while falling EBIT and EBITDA margins show that recent revenue has not translated efficiently into profit. This weakens earnings durability and reduces the buffer available for investment or shareholder returns.

Weak Cash ConversionPositive cash generation became less reliable as operating cash flow declined and free cash flow dropped sharply from 2024. Coverage of only about 19% of net income limits internally generated funding for debt reduction, dividends, and reinvestment.

Savencia News

Savencia’s Half-Year Results Show Acquisition-Driven Growth Amid Margin and Debt Pressures

The latest update is out from Savencia ( ($FR:SAVE) ). Savencia reported first-half 2026 sales of €3.486 billion,...

1M ago

Savencia Updates Share Capital and Voting Rights as of July 2026

Savencia ( ($FR:SAVE) ) has provided an update. Savencia reported that as of July 31, 2026, its share...

2M ago

Savencia (0DTK) Reveals Q2 Dividend: Here’s the Essential Information

Savencia (LSE: 0DTK) has declared, under its dividend policy, a yearly cash dividend in the amount of €1.60...

2y ago

Savencia (0DTK) Announces Q2 Dividend: Save the Dates!

Savencia (LSE: 0DTK) has declared, under its dividend policy, a yearly cash dividend in the amount of €1.40...

3y ago

SAVE FAQ

What was Savencia SA’s price range in the past 12 months?

Savencia SA lowest stock price was €54.20 and its highest was €74.40 in the past 12 months.

What is Savencia SA’s market cap?

Savencia SA’s market cap is €768.04M.

When is Savencia SA’s upcoming earnings report date?

Savencia SA’s upcoming earnings report date is Mar 11, 2027 which is in 149 days.

How were Savencia SA’s earnings last quarter?

Savencia SA released its earnings results on Sep 10, 2026. The company reported €2.913 earnings per share for the quarter.

Is Savencia SA overvalued?

According to Wall Street analysts Savencia SA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Savencia SA pay dividends?

Savencia SA pays a Annually dividend of €1.4 which represents an annual dividend yield of 2.5%. See more information on Savencia SA dividends here

What is Savencia SA’s EPS estimate?

Savencia SA’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Savencia SA have?

Savencia SA has 14,032,930 shares outstanding.

What happened to Savencia SA’s price movement after its last earnings report?

Savencia SA reported an EPS of €2.913 in its last earnings report. Following the earnings report the stock price went up 0.322%.

Which hedge fund is a major shareholder of Savencia SA?

Currently, no hedge funds are holding shares in FR:SAVE

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Savencia SA

Savencia SA is a French-headquartered enterprise, established in 1956, specializing in the production of dairy items for both domestic and international markets. The company's product portfolio encompasses a diverse range of cheeses, along with butters and creams supplied to consumer retail outlets and professional catering services. Additionally, it furnishes dairy ingredients for the food, nutrition, and healthcare sectors. Known as Bongrain SA until its rebranding in April 2015, the firm now operates under the name Savencia SA and is based in Viroflay, France.